| TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy CW Eskelund, C Dahl, JW Hansen, M Westman, A Kolstad, LB Pedersen, ... Blood, The Journal of the American Society of Hematology 130 (17), 1903-1910, 2017 | 375 | 2017 |
| Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells S Ek, CM Högerkorp, M Dictor, M Ehinger, CAK Borrebaeck Cancer research 62 (15), 4398-4405, 2002 | 251 | 2002 |
| Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma S Ek, M Dictor, M Jerkeman, K Jirström, CAK Borrebaeck Blood, The Journal of the American Society of Hematology 111 (2), 800-805, 2008 | 250 | 2008 |
| Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma M Dictor, S Ek, M Sundberg, J Warenholt, C György, S Sernbo, ... haematologica 94 (11), 1563, 2009 | 157 | 2009 |
| SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma–a Nordic Lymphoma Group study L Nordström, S Sernbo, P Eden, K Grønbaek, A Kolstad, R Räty, ... British journal of haematology 166 (1), 98-108, 2014 | 152 | 2014 |
| Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases A Carlsson, C Wingren, M Kristensson, C Rose, M Fernö, H Olsson, ... Proceedings of the National Academy of Sciences 108 (34), 14252-14257, 2011 | 122 | 2011 |
| The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer DJ Brennan, S Ek, E Doyle, T Drew, M Foley, G Flannelly, DP O’Connor, ... European journal of cancer 45 (8), 1510-1517, 2009 | 102 | 2009 |
| SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies E Gustavsson, S Sernbo, E Andersson, DJ Brennan, M Dictor, ... Molecular cancer 9 (1), 1-12, 2010 | 87 | 2010 |
| High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma E Björck, S Ek, O Landgren, M Jerkeman, M Ehinger, M Björkholm, ... Blood 105 (7), 2908-2915, 2005 | 82 | 2005 |
| The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation S Sernbo, E Gustavsson, DJ Brennan, WM Gallagher, E Rexhepaj, ... BMC cancer 11 (1), 1-10, 2011 | 64 | 2011 |
| Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference E Ortega-Paino, J Fransson, S Ek, CAK Borrebaeck Blood, The Journal of the American Society of Hematology 111 (3), 1617-1624, 2008 | 61 | 2008 |
| miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator S Husby, U Ralfkiaer, C Garde, R Zandi, S Ek, A Kolstad, M Jerkeman, ... Blood, The Journal of the American Society of Hematology 125 (17), 2669-2677, 2015 | 54 | 2015 |
| From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies S Ek, U Andréasson, S Hober, C Kampf, F Pontén, M Uhlén, H Merz, ... Molecular & Cellular Proteomics 5 (6), 1072-1081, 2006 | 48 | 2006 |
| Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4‐1BB‐L implicated in cell survival S Ek, E Björck, CM Högerkorp, M Nordenskjöld, A Porwit‐MacDonald, ... International journal of cancer 118 (8), 2092-2097, 2006 | 45 | 2006 |
| p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma JM Rodrigues, M Hassan, C Freiburghaus, CW Eskelund, C Geisler, ... British journal of haematology 191 (5), 796-805, 2020 | 42 | 2020 |
| Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis S Ek, E Bjorck, A Porwit-MacDonald, M Nordenskjold, CA Borrebaeck haematologica 89 (6), 686-695, 2004 | 42 | 2004 |
| Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo P Conrotto, U Andréasson, V Kuci, CAK Borrebaeck, S Ek Molecular oncology 5 (6), 527-537, 2011 | 41 | 2011 |
| Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells U Andréasson, M Dictor, M Jerkeman, M Berglund, C Sundström, ... American journal of hematology 84 (12), 803-808, 2009 | 38 | 2009 |
| Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma H Karvonen, D Chiron, W Niininen, S Ek, M Jerkeman, E Moradi, M Nykter, ... Blood advances 1 (24), 2257-2268, 2017 | 36 | 2017 |
| Expanded clinical and experimental use of SOX11-using a monoclonal antibody L Nordström, U Andréasson, M Jerkeman, M Dictor, C Borrebaeck, S Ek BMC cancer 12 (1), 1-11, 2012 | 31 | 2012 |
